Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors.

Mazzuti, Laura

Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors. [electronic resource] - AIDS (London, England) Aug 2017 - 1900-1901 p. digital

Publication Type: Case Reports; Journal Article

1473-5571

10.1097/QAD.0000000000001581 doi


Drug Resistance, Viral
HIV Infections--drug therapy
HIV Integrase--genetics
HIV Integrase Inhibitors--administration & dosage
HIV-1--enzymology
Heterocyclic Compounds, 3-Ring--administration & dosage
Humans
Male
Middle Aged
Mutation, Missense
Oxazines
Piperazines
Pyridones
Sustained Virologic Response
Treatment Outcome